Theranexus SA (ALTHX)

Currency in EUR
2.090
-0.070(-3.24%)
Real-time Data·
ALTHX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0502.180
52 wk Range
0.2613.660
Key Statistics
Prev. Close
2.16
Open
2.18
Day's Range
2.05-2.18
52 wk Range
0.261-3.66
Volume
25.44K
Average Volume (3m)
92.57K
1-Year Change
288.4758%
Book Value / Share
-0.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALTHX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.600
Upside
+120.10%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Theranexus SA Company Profile

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.

Compare ALTHX to Peers and Sector

Metrics to compare
ALTHX
Peers
Sector
Relationship
P/E Ratio
−10.1x−1.0x−0.6x
PEG Ratio
−0.470.010.00
Price/Book
−15.8x1.2x2.6x
Price / LTM Sales
34.0x3.3x3.4x
Upside (Analyst Target)
113.0%43.6%41.8%
Fair Value Upside
Unlock17.0%4.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.600
(+120.10% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Sep 24, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
806.04K / --
EPS Revisions
Last 90 days

ALTHX Income Statement

People Also Watch

4.07
DBV
-4.57%
104.60
ABVX
-1.88%
121.600
VIRI
-0.16%
6.01
IVAA
+0.50%
17.18
EDEN
-1.18%

FAQ

What Is the Theranexus (ALTHX) Stock Price Today?

The Theranexus stock price today is 2.090

What Stock Exchange Does Theranexus Trade On?

Theranexus is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Theranexus?

The stock symbol for Theranexus is "ALTHX."

What Is the Theranexus Market Cap?

As of today, Theranexus market cap is 28.83M.

What Is Theranexus's Earnings Per Share (TTM)?

The Theranexus EPS (TTM) is -0.31.

From a Technical Analysis Perspective, Is ALTHX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Theranexus Stock Split?

Theranexus has split 0 times.

How Many Employees Does Theranexus Have?

Theranexus has 10 employees.

What is the current trading status of Theranexus (ALTHX)?

As of Jan 26, 2026, Theranexus (ALTHX) is trading at a price of 2.090, with a previous close of 2.160. The stock has fluctuated within a day range of 2.050 to 2.180, while its 52-week range spans from 0.261 to 3.660.

What Is Theranexus (ALTHX) Price Target According to Analysts?

The average 12-month price target for Theranexus is EUR4.600, with a high estimate of EUR4.6 and a low estimate of EUR4.6. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +120.10% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.